Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 2,460,868 |
|
|||||
| News | (2) | ||||||
| Day High | 82.56 | Low High |
|||||
| Day Low | 79.77 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Moderna Inc | MRNA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 1.78 | 2.22% | 82.101 | 13:53:45 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 79.94 | 79.77 | 82.56 | 80.32 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 48,523 | 2,460,868 | US$ 81.88 | US$ 201,489,641 | - | 62.55 - 217.25 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 13:53:48 | 27 | US$ 82.3026 | USD |
Moderna (MRNA) Options Flow Summary
Moderna Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 31.4B | 381.28M | - | 19.26B | 8.36B | 21.93 | 3.76 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Moderna News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRNA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 79.56 | 84.12 | 77.40 | 79.96 | 3,226,142 | 2.54 | 3.19% |
| 1 Month | 69.59 | 84.12 | 67.62 | 77.74 | 3,136,145 | 12.51 | 17.98% |
| 3 Months | 114.205 | 114.30 | 62.55 | 84.04 | 3,989,504 | -32.10 | -28.11% |
| 6 Months | 123.36 | 133.1567 | 62.55 | 99.83 | 3,874,824 | -41.26 | -33.45% |
| 1 Year | 175.53 | 217.25 | 62.55 | 132.90 | 4,007,926 | -93.43 | -53.23% |
| 3 Years | 159.78 | 497.17 | 62.55 | 211.39 | 8,154,650 | -77.68 | -48.62% |
| 5 Years | 20.55 | 497.17 | 11.54 | 148.24 | 8,545,636 | 61.55 | 299.52% |
Moderna Description
| Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. |
